TAYLOR VALDETERO: Open Payments
NPI 1407252315 · CROWLEY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 33 payments from 16 companies in 2025. Trend: 2023 $827 · 2024 $470 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $95 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $62 |
| Novo Nordisk Inc | 3 | $55 |
| Abbott Laboratories | 3 | $54 |
| TOLMAR, INC. | 2 | $44 |
| ABBVIE INC. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Antares Pharma, Inc. | 2 | $33 |
Products named: XIFAXAN, MOUNJARO, Ozempic, FREESTYLE LIBRE 3, JATENZO, TRINTELLIX, Cologuard Collection Kit, JARDIANCE.
Industry payments across LA — which companies pay providers there.
